Table 2B.
Early Pandemic Period |
Late Pandemic Period |
|||||
---|---|---|---|---|---|---|
Model-Based % Screening Positive in May 2021‡ | Expected % Screening Positive in May 2021 If Prepandemic Trend Continued§ | Risk Difference (95% CI)║ | Model-Based % Screening Positive in May 2022‡ | Expected % Screening Positive in May 2022 If Prepandemic Trend Continued§ | Risk Difference (95% CI)║ | |
Overall | 7.3 | 4.5 | 2.8 (1.7, 3.8)* | 6.0 | 4.2 | 1.8 (0.9, 2.7)* |
Sex | ||||||
Female | 10.6 | 6.4 | 4.2 (2.9, 5.5)* | 8.3 | 6.1 | 2.2 (0.9, 3.6)* |
Male | 3.9 | 2.7 | 1.2 (0.2, 2.3)* | 3.5 | 2.3 | 1.2 (0.2, 2.2)* |
Payor | ||||||
Commercial | 6.2 | 3.6 | 2.6 (1.6, 3.6)* | 4.7 | 3.3 | 1.4 (0.5, 2.4)* |
Public | 9.5 | 6.7 | 2.8 (0.8, 4.7)* | 8.7 | 6.4 | 2.3 (0.3, 4.2)* |
Race and ethnicity | ||||||
Non-Hispanic White | 5.7 | 3.3 | 2.4 (1.3, 3.4)* | 4.8 | 2.9 | 1.9 (1.0, 2.7)* |
Non-Hispanic Black | 8.7 | 7.6 | 1.0 (−0.4, 2.4) | 8.1 | 7.9 | 0.2 (−1.3, 1.8) |
Other race and ethnicity¶ | 9.0 | 4.0 | 5.0 (3.1, 6.9)* | 6.2 | 3.3 | 2.9 (0.8, 5.0)* |
P < .05.
Prepandemic was defined as March 2018–February 2020. Data from March through May of 2020 were excluded due to low visit volume. The early pandemic period is June 2020–May 2021. The late pandemic period is June 2021–May 2022.
Estimated using logistic regression and marginal standardization. This represents the predicted percentage of adolescents screening positive for suicide risk at the start and end of the early and late pandemic periods, adjusting for seasonality.
This represents the predicted percentage of adolescents who would have screened positive for suicide risk at each time point, had the prepandemic trend continued.
Risk differences for the early and late pandemic periods represent the difference between the percentage of adolescents estimated by the model to have screened positive at each time point and the percentage that would have screened positive, had the prepandemic trend continued unchanged.
“Other race and ethnicity” patients include Hispanic, Asian, and other race patients.